Montarnaud, France

Daniel Da Costa

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 7.6

ph-index = 3

Forward Citations = 50(Granted Patents)


Location History:

  • Saint Jean de Vedas, FR (2013 - 2015)
  • Montarnaud, FR (2019 - 2020)

Company Filing History:


Years Active: 2013-2020

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovator Daniel Da Costa: Pioneering Antiviral Solutions

Introduction

Daniel Da Costa, a remarkable inventor based in Montarnaud, France, has made significant contributions to the field of pharmaceuticals through his innovative patents. With a total of five patents to his name, he has dedicated his research to developing compounds that address some of the most pressing health challenges, particularly in the realm of HIV and AIDS prevention and treatment.

Latest Patents

Among Daniel Da Costa's latest patents are groundbreaking antiviral aryl-amide phosphodiamide compounds, which are designed to inhibit HIV reverse transcriptase. These compounds show promise not only in treating HIV infections but also in preventing the onset and progression of AIDS. Additionally, he has developed antiviral aliphatic ester prodrugs of tenofovir, which also target HIV reverse transcriptase. Both classes of compounds and their pharmaceutically acceptable salts can be effectively utilized as ingredients in pharmaceutical compositions, often in combination with other antiviral agents, immunomodulators, antibiotics, or vaccines.

Career Highlights

Throughout his career, Daniel has had the privilege of working with prominent companies in the pharmaceutical industry, including Idenix Pharmaceuticals and Merck Sharp & Dohme Corporation. His experience in these esteemed organizations has allowed him to refine his expertise and contribute to significant advancements in antiviral medications.

Collaborations

Collaboration has played a crucial role in Daniel Da Costa's journey as an inventor. He has worked alongside talented individuals such as David Dukhan and Houcine Rahali, fostering an environment of innovation and shared knowledge to drive his projects forward.

Conclusion

In summation, Daniel Da Costa stands out as an inventive force in the pharmaceutical industry, particularly with his focus on developing effective treatments and preventive measures against HIV and AIDS. His patents reflect a commitment to advancing medical science and improving patient outcomes through innovation. As he continues his research and development efforts, the impact of his work is expected to resonate within the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…